Medical Marijuana

First Steps:

1. The patient must register on the PA Medical Marijuana Patient Registry website at https://padohmmp.custhelp.com/app/login.
2. The patient can then set up an appointment with one of our providers to obtain a medical marijuana certification. The patient must present a diagnosis and history that confirm one of the state’s listed qualifying conditions for medical marijuana to our providers. 
3. Once diagnosis is confirmed and certification is provided, the patient will complete their registration online and will pay $50 for their medical marijuana ID card.
4. Patient can then visit a dispensary in their area with the ID card, to meet with dispensary staff and determine the optimal formulation for their diagnosis.

If you have any questions please email Patients@zabreckyinstitute.com for assistance.

Pricing:

Our pricing structure is as follows:

• First-time visit: $150.00. This includes evaluation of our intake form, verification of previously established diagnosis, and certification at the end of the visit.
  • Proof of Medical History is required. Any documentation must clearly state your diagnosis. Example documentation includes an after-visit summary of your doctor's visit; a print-out of your diagnosis from a patient portal; imaging report; a note from any healthcare provider, PCP, specialist, or behavioral health counselor stating your diagnosis. Documentation does not have to be in-depth or recent.

• Renewal of Certification: $75.00
• First-time visit & Anxiety Diagnosis: $175.00. This includes evaluation of our intake form, diagnosis of anxiety, and certification at the end of the visit.
• Length of appointments: 15-20 minutes.
• Insurance accepted: No.

Conditions treated with medical marijuana include the following:

• Amyotrophic lateral sclerosis
• Anxiety disorders
• Autism
• Cancer; including remission therapy
• Crohn's disease
• Damage to the nervous tissue of the central nervous system (brain-spinal chord) with objective neurological indication of intractable spasticity, and other associated neuropathies
• Dyskinetic and spastic movement disorders
• Epilepsy
• Glaucoma
• HIV/AIDS
• Huntington's disease
• Inflammatory bowel disease
• Intractable seizures
• Multiple sclerosis
• Neurodegenerative diseases
• Neuropathies
• Opioid use disorder for which conventional therapeutic interventions are contraindicated or ineffective, or for which adjuctive therapy is indicated in combination with primary therapeutic interventions
• Parkinson's disease
• PTSD
• Severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain
• Sickle cell anemia
• Terminal illness
• Tourette syndrome